Anatomic Pathology Market is Estimated to Develop at a CAGR of 7.0% during the Forecast Period, notes MnM Study

The growth of this Anatomic Pathology market is mainly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, reimbursement possibilities, and growing interest in personalized medicines.

[343 Pages Report] The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Report Scope and Market Segmentation:

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2022–2026

Forecast Units

Value (USD Billion)

Segments Covered

By product & service, application, end user, and region.

Geographies Covered

North America, Europe, APAC, LATAM, and MEA

Companies Covered

F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Beckton, Dickson and Company (US),  Abcam plc. (UK), Hologic, Inc. (US), Agilent Technologies (US), Merck KGaA (Germany), Sakura Finetek (US), Bio SB (US), BioGenex (US), Milestone Medical (Italy), Histo-Line Laboratories (Italy), Diapath S.p.A (Italy), SLEE medical GmbH (Germany), Amos Scientific Pty Ltd (Australia), MEDITE Medical GmbH (Germany), Cell Signaling Technology, Inc. (US), CellPath Ltd. (UK), Jinhua Yidi Medical Equipment Co., Ltd. (China), MICROS AUSTRIA (Austria), R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED (India), Lupetec (Brazil), Medimeas (India), and Bright Instruments (UK).

 

Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market

Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments. The services segment accounted for the largest market share. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

By Application, disease diagnostics accounted for the largest market share

Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market

By End User, Hospital laboratories accounted for the largest market share

Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories accounted for the largest share

North America dominates the anatomic pathology market

North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

F. Hoffmann-La Roche AG (Switzerland) is the leading player in the anatomic pathology market in 2020. The company has a wide range of products in the consumables segment. Strong business operations across all key regions, coupled with a strong brand image, make the firm a leading player in this market.

Comments

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™

Sterilization Services Market worth $5.49 billion by 2030